Jennifer Vieira
Investor Relations
Replay available
Enanta Pharmaceuticals, Inc. (ENTA) Q2 2023 Earnings Call
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) Q2 2023 earnings conference call, held 2023-05-08. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Jay Lulli
President & Chief Executive Officer
Dr. Scott Rottinghaus
Chief Medical Officer
Paul Mellett
Chief Financial Officer
Jasmine Rahimi
Analyst, Piper Sandler
Brian Abrahams
Analyst, RBC Capital Markets
Akash Tiwari
Analyst, Jefferies
Roana Ruiz
Analyst, SBB Securities
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Enanta Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:04.013 Good afternoon and welcome to Enanta Pharmaceuticals' first call. 00:00:04.013 -- 00:00:07.016 Second quarter ended March 00:00:07.016 -- 00:00:10.299 31st, 2023 Financial Results Conference call. 00:00:10.299 -- 00:00:13.682 At this time, all participants are in a listen-only mode. 00:00:13.682 -- 00:00:17.466 There will be a question and answer session at the end of the preparing marks. 00:00:17.466 -- 00:00:20.368 Please be advised that this call is being recorded. 00:00:20.368 -- 00:00:24.592 I would now like to turn the call over to Jennifer Vieira, Investor Relations. 00:00:24.592 -- 00:00:26.630 Please go ahead. 00:00:26.630 -- 00:00:30.572 Thank you, Operator, and thanks to everyone for joining us this afternoon. 00:00:30.572 -- 00:00:35.675 The news release with our fiscal second quarter 2023 financial results was 00:00:35.675 -- 00:00:39.296 issued this afternoon and is available on our website. 00:00:39.296 -- 00:00:43.759 A news release with top line data from our SPRINT clinical trial was also issued this 00:00:43.759 -- 00:00:46.640 afternoon and can be found on our website as well. 00:00:46.640 -- 00:00:52.083 Slides from today's webcast will be available on our website after the call ends. 00:00:52.083 -- 00:00:57.058 On the call today are Dr. Jay Lulai, our President and Chief Executive Officer, Dr. 00:00:57.058 -- 00:01:02.662 Scott Rottinghaus, our Chief Medical Officer, Paul Mellett, our Chief Financial Officer, 00:01:02.662 -- 00:01:08.566 and Dr. Tara Kiefer, our Senior Vice President of New Product Strategy and Development. 00:01:08.566 -- 00:01:12.548 Before we begin with our formal remarks, we do want to remind you that we will be making 00:01:12.548 -- 00:01:17.091 forward-looking statements, which may inc...